The Europe smart inhalers market is expected to reach US$ 2,129.61 Mn in 2027 from US$ 302.40 Mn in 2018. The market is estimated to grow with a CAGR of 24.9% from 2019-2027.
The growth of the smart inhalers market is driven by the factors such as, growing geriatric population rising prevalence of COPD and asthma, along with rising awareness regarding the medical condition. However, the market is likely to get impacted due to risks associated with cyber threats limited knowledge regarding the use of smart inhalers.
With rapid urbanization there has been growth in various adverse factors that have led to the growth of respiratory diseases across the Europe. Some of the factors leading to growth in the number of asthma and COPD cases across the Europe are rise in air pollution levels and increasing smoking habits.
The rise in air pollution levels has been a matter of rising concern in developed as well as developing economies. As per data published by the World Health Organization (WHO) released during May 2018, 9 out of 10 individuals are believed to breathe air containing high levels of pollutants. Data published by WHO reveals that approximately 7 million people die every year due to exposure to fine particles present in polluted air, which penetrate deep into lungs and the cardiovascular system. This leads to various diseases such as lung cancer, pneumonia, chronic obstructive pulmonary diseases and respiratory infections, among others. Studies reveal, above 90% of air pollution-related deaths worldwide occur in low- and middle-income countries of the Eastern Mediterranean, European regions. According to world health organization (WHO), about 21,000 premature deaths per year in European region because of air pollution like Ozone pollution courses breathe difficulties, triggers asthma symptoms, and causes lung and heart diseases. Additionally increasing indirect effects of air pollution like growing climate change, because of transport is the fastest growing source of fossil-fuel emissions of carbon dioxide (CO2) which is a largest contributor of the climate change. As per data published by World Health Organization (WHO) Some 40 million people in the 115 largest cities in the European Union (EU) are exposed to air exceeding WHO air quality guideline values for at least one pollutant. Children living near roads with heavy-duty vehicle traffic have twice the risk of respiratory problems as those living near less congested streets. Hence, the rising levels of air pollution coupled is anticipated to drive the demand for smart inhalers market during the forecast period.
In 2018, the inhalers segment held a largest market share of the smart inhalers market, by product. The inhalers is expected to dominate its market share in 2027 owing to the increasing mortality rate of asthma. The inhalers segment is also anticipated to witness the fastest growth rate during the forecast period, 2019 to 2027.
UK is expected to lead the market in the Europe region because the growing prevalence of asthma and COPD Across the country. According to the data published in Asthma UK, in 2016 to 2017 there were 77,124 admissions to hospital for asthma in the UK and in 2017 1,484 people in the UK died from an asthma attack in the UK. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the Europe region during the forecast period.
Italy Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
EUROPE SMART INHALERS - MARKET SEGMENTATION
By Product
- Inhalers
- Nebulizers
By Disorder
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
By End User
- Home-care Settings
- Hospitals & Clinics
By Geography
Europe
- UK
- Germany
- France
- Spain
- Italy
Company Profiles
- GlaxoSmithKline plc
- Adherium Ltd.
- Vectura Group plc
- Novartis AG
- Findair Sp. z o. o.
- Cohero Health
- Crux Product Design Ltd
- Teva Pharmaceuticals
- 3M
- Amiko Digital Health Limited
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Disorder, End User, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
UK, Germany, France, Italy, Russia
1. Introduction
1.1 Scope Of The Study
1.2 The Insight Partners Research Report Guidance
2. Europe Smart Inhalers Market – Key Takeaways
3. Europe Smart Inhalers Market – Market Landscape
3.1 Overview
3.2 Market Segmentation
3.2.1 Europe Smart Inhalers Market – By Product
3.2.2 Europe Smart Inhalers Market – By Disorder
3.2.3 Europe Smart Inhalers Market – By End User
3.2.4 Europe Smart Inhalers Market – By Europe Region
3.3 Pest Analysis
4. Europe Smart Inhalers Market – Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Increasing Levels of Air Pollution as well as Rise in the Smoking Habits
4.1.2 Rising Prevalence of Asthma and COPD Across the Europe
4.1.3 Growing Geriatric Population
4.2 Key Market Restraints
4.2.1 Risks Associated with Cyber Threats
4.2.2 Limited Knowledge Regarding the Use of Smart Inhalers
4.3 Key Market Opportunity
4.3.1 Growth in the Global Healthcare Market
4.4 Future Trend
4.4.1 Increasing Acceptance of Mobile Health Technology
4.5 Impact Analysis
5. Smart Inhalers Market – Europe Analysis
5.1 Europe Smart Inhalers Market Revenue Forecasts And Analysis
5.2 Performance Of Key Players
6. Smart Inhalers Market Analysis And Forecasts To 2027 – Product
6.1 Overview
6.2 Europe Smart Inhalers Market Share By PRODUCT 2018 & 2027 (%)
6.3 Inhalers Market
6.3.1 Overview
6.3.2 Inhalers Market Revenue and Forecast to 2027 (US$ Mn)
6.4 Nebulizers Market
6.4.1 Overview
6.4.2 Nebulizers Market Revenue and Forecast to 2027 (US$ Mn)
7. Smart Inhalers Market Analysis And Forecasts To 2027 – Disorder
7.1 Overview
7.2 Europe Smart Inhalers Market Share By Application 2018 & 2027 (%)
7.3 Asthma Diabetes
7.3.1 Overview
7.3.2 Asthma Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Chronic Obstructive Pulmonary Disease Market
7.4.1 Overview
7.4.2 Chronic Obstructive Pulmonary Disease Market Revenue and Forecast to 2027 (US$ Mn)
8. Smart Inhalers Market Analysis And Forecasts To 2027 –End User
8.1 Overview
8.2 Europe Smart Inhalers Market Share By End User 2018 & 2027 (%)
8.3 Hospitals & Clinics Market
8.3.1 Overview
8.3.2 Hospitals & Clinics Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Home Care Settings Market
8.4.1 Overview
8.4.2 Home-Care Settings Market Revenue and Forecast to 2027 (US$ Mn)
9. Smart Inhalers Market Revenue And Forecasts To 2027 – Europe Analysis
9.1 Europe Smart Inhalers Market Revenue And Forecasts To 2027
9.1.1 Europe Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.2 Europe Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.3 Europe Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)
9.1.4 Europe Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.5 Europe Smart Inhalers Market Revenue And Forecasts to 2027, By Country (%)
9.1.6 UK Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.6.1 UK Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.6.2 UK Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.6.3 UK Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)
9.1.6.4 UK Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.7 Germany Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.1 Germany Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.2 Germany Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.7.3 Germany Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)
9.1.7.4 Germany Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.8 France Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.8.1 France Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.8.2 France Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.8.3 France Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)
9.1.8.4 France Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.9 Italy Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.9.1 Italy Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.9.2 Italy Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.9.3 Italy Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)
9.1.9.4 Italy Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.10 Spain Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.10.1 Spain Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.10.2 Spain Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.10.3 Spain Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)
9.1.10.4 Spain Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10. Smart Inhalers Market– Industry Landscape
10.1 Overview
10.2 Comparative Company Analysis
10.3 Growth Strategies Done By The Companies In The Market, (%)
10.4 Organic Developments
10.4.1 Overview
10.5 Inorganic Developments
10.5.1 Overview
11. Smart Inhalers Market–Key Company Profiles
11.1 Glaxosmithkline Plc.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Overview
11.1.4 Product Portfolio
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Adherium Limited
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Financial Overview
11.2.4 Product Portfolio
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Novartis AG
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Overview
11.3.4 Product Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Vectura Group Plc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Financial Overview
11.4.1 Product Portfolio
11.4.2 SWOT Analysis
11.4.3 Key Developments
11.5 Cohero Health, Inc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Financial Overview
11.5.4 Product Portfolio
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Crux Product Design Ltd
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial Information
11.6.4 Product Portfolio
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Findair Sp. Z O. O.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Product Portfolio
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Teva Pharmaceutical Industries Ltd.
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Overview
11.8.4 Product Portfolio
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 3M
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Financial Overview
11.9.4 Product Portfolio
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Amiko Digital Health Limited
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial Overview
11.10.4 Product Portfolio
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary Of Terms
LIST OF TABLES
Table 1. Total Number Of Persons Aged 60 Years Or Above By Region, 2017 & 2050
Table 2. Europe Smart Inhalers Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 3. Europe Smart Inhalers Market Revenue And Forecasts To 2027, By Disorder (US$ Mn)
Table 4. Europe Smart Inhalers Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 5. UK Smart Inhalers Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 6. UK Smart Inhalers Market Revenue And Forecasts To 2027, By Disorder (US$ Mn)
Table 7. UK Smart Inhalers Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 8. Germany Smart Inhalers Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 9. Germany Smart Inhalers Market Revenue And Forecasts To 2027, By Disorder (US$ Mn)
Table 10. Germany Smart Inhalers Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 11. France Smart Inhalers Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 12. France Smart Inhalers Market Revenue And Forecasts To 2027, By Disorder (US$ Mn)
Table 13. France Smart Inhalers Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 14. Italy Smart Inhalers Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 15. Italy Smart Inhalers Market Revenue And Forecasts To 2027, By Disorder (US$ Mn)
Table 16. Italy Smart Inhalers Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 17. Spain Smart Inhalers Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 18. Spain Smart Inhalers Market Revenue And Forecasts To 2027, By Disorder (US$ Mn)
Table 19. Spain Smart Inhalers Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 20. Organic Developments Done By Companies
Table 21. Inorganic Developments Done By Companies
Table 22. Glossary Of Terms, Smart Inhalers Market
LIST OF FIGURES
Figure 1. UK Smart Inhalers Market, Revenue (US$ Mn), 2018 & 2027
Figure 2. Europe Smart Inhalers Market By Product, Market Share (%), 2018
Figure 3. Europe Smart Inhalers Market By Disorder, Market Share (%), 2018
Figure 4. Europe Smart Inhalerss Market By End User, Market Share (%), 2018
Figure 5. Smart Inhalers Market Segmentation
Figure 6. Europe Pest Analysis
Figure 7. Global Smart Inhalers Market Impact Analysis Of Driver And Restraints
Figure 8. Europe Smart Inhalers Market – Revenue Forecasts And Analysis –2018- 2027
Figure 9. Market Positioning Of Key Player In Europe Smart Inhalers Market
Figure 10. Europe Smart Inhalers Market Share By Product 2018 & 2027 (%)
Figure 11. Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 12. Nebulizers Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 13. Europe Smart Inhalers Market Share By Application 2018 & 2027 (%)
Figure 14. Asthma Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 15. Chronic Obstructive Pulmonary Disease Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 16. Europe Smart Inhalers Market Share By End User 2018 & 2027 (%)
Figure 17. Hospitals & Clinics Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 18. Home-Care Settings Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 19. Europe Smart inhalers Market REVENUE overview, by Country, 2018 (US$ MN)
Figure 20. Europe Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Europe Smart Inhalers Market Revenue And Forecasts to 2027, By Country (%)
Figure 22. UK Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. Germany Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. France Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. Italy Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. Spain Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 27. Comparative Company Analysis
Figure 28. Growth Strategies done by the companies in the Market, (%)
The List of Companies - Europe Smart Inhalers Market
- GlaxoSmithKline plc
- Adherium Ltd.
- Vectura Group plc
- Novartis AG
- Findair Sp. z o. o.
- Cohero Health
- Crux Product Design Ltd
- Teva Pharmaceuticals
- 3M
- Amiko Digital Health Limited
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Europe Smart Inhalers Market
Oct 2019
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Oct 2019
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2019
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2019
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2019
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2019
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2019
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Oct 2019
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)